Literature DB >> 23617240

The regulation of T-cell recruitment to the human liver during acute liver failure.

Ceren Tuncer1, Ye H Oo, Nick Murphy, David H Adams, Patricia F Lalor.   

Abstract

BACKGROUND & AIMS: Acute liver failure (ALF) is a rare clinical syndrome with high mortality resulting from hepatocellular necrosis and loss of function. In seronegative hepatitis (SNH), a T-cell-rich infiltrate leads to immune-mediated hepatocyte destruction, whereas in paracetamol poisoning, toxic metabolites induce hepatocyte necrosis, followed by a macrophage-rich, lymphocytic infiltrate that is an important factor in driving repair and regeneration. The nature of the hepatic inflammatory infiltrate, key to ALF pathogenesis and outcome, is determined by the recruitment of effector cells from blood, but the molecular basis of recruitment is poorly understood. To determine the phenotype of circulating and hepatic lymphocytes in patients with ALF secondary to paracetamol overdose (POD) or SNH and investigate the molecular basis of lymphocyte recruitment.
METHODS: We used FACS, immunohistochemistry and flow-based adhesion assays to determine the regulation of lymphocyte adhesion.
RESULTS: SNH and POD intrahepatic lymphocytes were αLβ2(hi), CD69(hi) and CD38(hi) with a distinct homing phenotype being L-selectin(lo), CXCR3(hi) and CCR5(+). Expression of chemokine ligands for the receptors CCR5, CXCR3 and CXCR6 and the adhesion molecules ICAM-1, VCAM-1 and VAP-1 was markedly increased in the liver in ALF. Lymphocytes isolated from the livers of patients with SNH showed enhanced chemokine-dependent adhesion and transmigration across the human hepatic endothelium in vitro under flow and used a combination of β1 and β2 integrins to adhere to endothelium and β2 integrins, CD31 and VAP-1 to transmigrate.
CONCLUSION: Aetiology-dependent combinations of adhesion molecules and chemokines expressed within tissue during ALF recruit lymphocytes with a distinct homing phenotype.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23617240     DOI: 10.1111/liv.12182

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

1.  T helper cell dysregulation with hepatitis B and rebalance with glucocorticoids.

Authors:  Zhong-Hua Lu; Xiao-Ping Huang; Wei Sun; Yi-Ling Zhu; Juan-Juan Cui; Wei Chen; Li-Hua Huang; Shou-Gang Kuai; He-Juan Du; Zhao-Xia Ju; Jian-He Gan
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 2.  Immune mechanisms in acetaminophen-induced acute liver failure.

Authors:  Oliver Krenkel; Jana C Mossanen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

3.  Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross.

Authors:  Rabea A Hall; Sonja Hillebrandt; Frank Lammert
Journal:  Mamm Genome       Date:  2015-11-07       Impact factor: 2.957

4.  Critical role of OX40 in drug-induced acute liver injury.

Authors:  Chunpan Zhang; Hua Jin; Yan Wang; Changying Li; Xinyan Zhao; Yanmeng Li; Wen Shi; Yue Tian; Hufeng Xu; Dan Tian; Kai Liu; Jidong Jia; Guangyong Sun; Dong Zhang
Journal:  Br J Pharmacol       Date:  2020-04-05       Impact factor: 8.739

5.  Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.

Authors:  Alexander Wehr; Christer Baeck; Florian Ulmer; Nikolaus Gassler; Kanishka Hittatiya; Tom Luedde; Ulf Peter Neumann; Christian Trautwein; Frank Tacke
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

6.  Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices.

Authors:  Kai Sun; Xuqin Xie; Jing Xie; Shufan Jiao; Xiaojing Chen; Xue Zhao; Xin Wang; Lixin Wei
Journal:  Sci Rep       Date:  2014-09-29       Impact factor: 4.379

7.  Direct evidence for activated CD8+ T cell transmigration across portal vein endothelial cells in liver graft rejection.

Authors:  Taro Kariya; Hisashi Ueta; Xue-Dong Xu; Daisuke Koga; Taichi Ezaki; Enqiao Yu; Satoshi Kusumi; Yusuke Kitazawa; Yasushi Sawanobori; Tatsuo Ushiki; Thomas Issekutz; Kenjiro Matsuno
Journal:  J Gastroenterol       Date:  2016-02-18       Impact factor: 7.527

8.  Chemoprophylaxis with sporozoite immunization in P. knowlesi rhesus monkeys confers protection and elicits sporozoite-specific memory T cells in the liver.

Authors:  Sathit Pichyangkul; Michele D Spring; Kosol Yongvanitchit; Utaiwan Kum-Arb; Amporn Limsalakpetch; Rawiwan Im-Erbsin; Ratawan Ubalee; Pattaraporn Vanachayangkul; Edmond J Remarque; Evelina Angov; Philip L Smith; David L Saunders
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

Review 9.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.

Authors:  Carl Randall Harrell; Crissy Fellabaum; Nemanja Jovicic; Valentin Djonov; Nebojsa Arsenijevic; Vladislav Volarevic
Journal:  Cells       Date:  2019-05-16       Impact factor: 6.600

Review 10.  SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Authors:  Mercedes Unzeta; Mar Hernàndez-Guillamon; Ping Sun; Montse Solé
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.